Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Engineering Oncolytic Measles Virus with MG53 Couples Pyroptotic Tumor Killing with Immune Microenvironment Remodeling to Enhance Checkpoint Immunotherapy in Non-small Cell Lung Cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 01, 2026
Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV.
Journal: Science advances
Published: September 26, 2025
A Rapid Yeast-Based System for Modifying Respiratory Syncytial Virus.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 29, 2025
Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 06, 2025
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.
Journal: Journal of virology
Published: March 26, 2025
Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants.
Journal: mBio
Published: March 26, 2025
Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024
Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants.
Journal: bioRxiv : the preprint server for biology
Published: September 16, 2024
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion.
Journal: bioRxiv : the preprint server for biology
Published: June 03, 2024
Last Updated: 09/26/2026